Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment
Clinical trial NCT04820023 · TERMINATED
Trial details
- NCT number
- NCT04820023
- Sponsor
- Bridge Biotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-02
- Primary completion
- 2023-11-29
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.